One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Anticoagulation in atrial fibrillation and implantable cardioverter defibrillator implantation in arrhythmogenic right ventricular cardiomyopathy: need for improving patient selection
doi : 10.1093/eurheartj/ehae070
Volume 45, Issue 7, 14 February 2024
Visualizing the unseen: lights and shadows of imaging in the electrophysiology laboratory
Cutting tall poppies down to size lessons from the tyrants of ancient Rome
Breaking down barriers to transcatheter aortic-valve implantation in low surgical risk patients
The year in cardiovascular medicine 2023: the top 10 papers in dyslipidaemias
The year in cardiovascular medicine 2023: the top 10 papers in heart failure and cardiomyopathies
Atrial fibrillation progression after cryoablation vs. radiofrequency ablation: the CIRCA-DOSE trial
Deciphering connections: how is cryoablation interlinking with disease progression in atrial fibrillation ablation?
Oral anticoagulation after atrial fibrillation catheter ablation: benefits and risks
Interruption of oral anticoagulants after atrial fibrillation catheter ablation: the importance of risk stratification
Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe
Transatlantic differences in the use of implantable cardioverter defibrillators in arrhythmogenic right ventricular cardiomyopathy
A very rare and unusual complication after a percutaneous patent foramen ovale closure
10-Year optical coherence tomography follow-up of ‘full-plastic jacket’ with bioresorbable vascular scaffolds
Correction to: 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC)
